Sr Brand Manager - Cardiometabolic Health at Eli Lilly and Company

Toronto, Ontario, Canada

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

University degree
7+ years of marketing related experience
Experience with brand management: launching new products/NILEX management an asset
Extensive omnichannel marketing experience
Teamwork and leadership – proven ability to partner with and engage others towards a common goal
Experimentation and Risk Taking – proven track record of pursuing non-conventional ways to meet customer needs and enhance the customer experience
Learning agility and high comfort with change in a high-stake environment
Project Management – ability to manage detailed, complex projects
Business acumen skills – budget management, strategic trade-offs, development and monitoring of lead measures
Excellent interpersonal, written, and verbal communication skills
Proficient computer skills (Excel, Word and PowerPoint)
Consumer marketing experience an asset
TA experience: Understanding metabolic disorders and the competitive environment in CWM and Diabetes an asset
Bilingualism is an asset

Responsibilities

Driving the strategic development and implementation of our molecule in CWM and Diabetes
Informing and supporting our continued transformation agenda and institutionalizing commercial shifts necessary to successfully deliver on the CWM and Diabetes strategy
Gaining deep customer insights across patients, payers and HCPs to inform our brand strategy in a rapidly evolving market
Defining Lilly Canada’s consumer activation roadmap for our molecule including the development of consumer marketing strategy, leading discussions with senior management on capabilities, strategy, and execution necessary to drive consumer activation in Canada
Leadership of the customer planning process and operational plan process for pre-NOC and post NOC activities
Partnering with the Global and IBU teams to ensure alignment on strategy and efficient use of common resources
Driving and leading the launch preparation partnership process in collaboration with the cross functional local and global teams
Managing of the overall commercial brand budget for pre and post launch
Driving innovative thinking across the cross functional team for a bold and comprehensive pre and post launch OCE plans
Ensuring pre-launch milestones are being met to enable our successful launch in chronic weight management (CWM) and Diabetes
Playing a critical role in developing the launch plans; from thought leader engagement, environmental shaping, go to market strategy, consumer activation and other deliverables related to the launch
Working closely with global, IBU and local cross functional teams to lead the development and implementation of our launch plans, brand strategy and tactics

Skills

Brand Management

Launch Planning

Thought Leader Engagement

Go-to-Market Strategy

Consumer Activation

Customer Insights

Marketing Strategy

Cross-Functional Collaboration

Pharmaceutical Marketing

Strategic Development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free